neuraxpharm

Private

Last Round

Debt

Jul 11, 2025

Last Round Size

$1.9B

Est. Valuation

$1.9B

Total Funding Raised

$1.9B

Company Overview

A specialty pharmaceutical company focused on the treatment of the central nervous system (CNS).

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Compare neuraxpharm with similar companies based on industry and business-model similarity.

Access detailed peer comparisons, similarity scores, and market data.

Historical fundraising activity

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about neuraxpharm's valuation, stock price, and market status.

Headquarters—

Year Founded1985

Last FundingJul 11, 2025

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.